Elutia Long Term Debt Over Time
| ELUT Stock | 3.20 0.01 0.31% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Elutia Performance and Elutia Correlation. Elutia |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elutia. If investors know Elutia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elutia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Elutia Inc is measured differently than its book value, which is the value of Elutia that is recorded on the company's balance sheet. Investors also form their own opinion of Elutia's value that differs from its market value or its book value, called intrinsic value, which is Elutia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elutia's market value can be influenced by many factors that don't directly affect Elutia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elutia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elutia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elutia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Long Term Debt Analysis
Compare Elutia Inc and related stocks such as Nuvalent, Arcellx, and Vaxcyte Long Term Debt Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUVL | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.6 M | 2.4 M |
| PCVX | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.6 M | 450 K | 450 K | 450 K | 450 K | 450 K | 405 K | 384.8 K |
| CRNX | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 163 K | 146.7 K | 130.4 K |
| CYTK | 7.1 M | 0.0 | 0.0 | 0.0 | 0.0 | 14.6 M | 27.4 M | 31.8 M | 39.8 M | 45.1 M | 46.2 M | 47.4 M | 63.8 M | 607.4 M | 698.5 M | 733.4 M |
| PLRX | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 10.1 M | 11.6 M | 11 M |
| SNDX | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 8 K | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 19.9 M | 19.9 M | 19.9 M | 22.9 M | 12.4 M |
| INZY | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 44.8 M | 51.5 M | 26.9 M |
Elutia Inc and related stocks such as Nuvalent, Arcellx, and Vaxcyte Long Term Debt description
Long-term debt is a debt that Elutia Inc has held for over one year. Long-term debt appears on Elutia Inc balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Elutia Inc balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.My Equities
My Current Equities and Potential Positions
| Elutia Inc | ELUT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Maryland; U.S.A |
| Exchange | NASDAQ Exchange |
null 3.2
Additional Tools for Elutia Stock Analysis
When running Elutia's price analysis, check to measure Elutia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elutia is operating at the current time. Most of Elutia's value examination focuses on studying past and present price action to predict the probability of Elutia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elutia's price. Additionally, you may evaluate how the addition of Elutia to your portfolios can decrease your overall portfolio volatility.